Chicago Partners Investment Group LLC Purchases 497 Shares of CME Group Inc. (NASDAQ:CME)

Chicago Partners Investment Group LLC grew its position in CME Group Inc. (NASDAQ:CME) by 1.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 26,675 shares of the financial services provider’s stock after buying an additional 497 shares during the period. Chicago Partners Investment Group LLC’s holdings in CME Group were worth $6,059,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in CME. CVA Family Office LLC lifted its stake in CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after buying an additional 46 shares in the last quarter. Lester Murray Antman dba SimplyRich raised its holdings in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares during the period. Essex LLC lifted its position in CME Group by 3.3% in the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock valued at $355,000 after acquiring an additional 52 shares in the last quarter. Quent Capital LLC boosted its stake in CME Group by 10.2% in the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after purchasing an additional 55 shares during the period. Finally, Grove Bank & Trust increased its holdings in CME Group by 1.3% during the 3rd quarter. Grove Bank & Trust now owns 4,276 shares of the financial services provider’s stock worth $943,000 after purchasing an additional 55 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Down 0.8 %

Shares of CME stock opened at $223.61 on Friday. The stock has a market cap of $80.52 billion, a P/E ratio of 23.51, a price-to-earnings-growth ratio of 5.72 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a 50 day simple moving average of $220.69 and a 200 day simple moving average of $209.46.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 earnings per share. CME Group’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.06%. CME Group’s payout ratio is presently 48.37%.

Analysts Set New Price Targets

CME has been the topic of a number of research reports. JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Barclays upped their price target on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Bank of America lifted their price objective on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. The Goldman Sachs Group increased their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $222.73.

Insider Activity

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,221 shares of company stock valued at $3,351,895 over the last quarter. 0.30% of the stock is owned by company insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.